Indian firms have been focusing on complex generics for some time now, which insulates them partially from pricing pressures ...

Every day, manufacturers continue to develop new, life-saving cancer treatments, and breakthroughs in oncology promise ... Development-phase companies need to establish distribution networks ...

The agreement stipulates that projects will be co-selected, drawing on shared interests and areas of expertise.

The tariff war has prompted new calls to reshore manufacturing. Several large pharmas have already made the leap.

Novartis will invest $23bn in US-based manufacturing and research and development (R&D) over the next five years, becoming ...

At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...